Torres-Ferrus, Marta
Pareto, Deborah
Gallardo, Victor J
Cuberas-Borrós, Gemma
Alpuente, Alicia
Caronna, Edoardo
Vila-Balló, Adrià
Lorenzo-Bosquet, Carles
Castell-Conesa, Joan
Rovira, Alex
Pozo-Rosich, Patricia
Funding for this research was provided by:
Spanish Neurological Society (The Headache Study Group Grant 2016)
Mutual Medica (Mutual Medica Grant 2016)
“la Caixa” Foundation (LCF/PR/PR16/151110005)
Article History
Received: 24 May 2021
Accepted: 6 July 2021
First Online: 17 July 2021
Declarations
:
: The study was approved by Vall d’Hebron Ethics Committee (PR(IR)40/2016).Subjects’ written informed consent was obtained according to the Declaration of Helsinki.
: Subjects gave consent for the publication of data.
: Torres-Ferrus M has received honoraria as a consultant or speaker for Allergan-Abbvie, Almirall, Chiesi, Eli Lilly, Novartis and Teva. Pareto D has received speaking honoraria from Novartis and Sanofi-Genzyme. Alpuente A has received honoraria as a consultant or speaker for Allergan-Abbvie, Chiesi and Novartis. Rovira A serves on scientific advisory boards for Novartis, Sanofi-Genzyme, SyntheticMR, Bayer, Roche, Biogen, and OLEA Medical, and has received speaker honoraria from Sanofi-Genzyme, Bracco, Merck-Serono, Teva Pharmaceutical Industries Ltd, Novartis, Roche and Biogen. Lorenzo-Bosquet C has received honoraria as speaker for GE Healthcare. Pozo-Rosich P has received honoraria as a consultant and speaker for: Allergan-Abbvie, Almirall, Amgen, Biohaven, Chiesi, Eli Lilly, Medscape, Neurodiem, Novartis and Teva. Her research group has received research grants from Allergan, and has received funding for clinical trials from Alder, Allergan-Abbvie, Electrocore, Eli Lilly, Novartis and Teva. She is a trustee member of the board of the International Headache Society, member of the Council of the European Headache Society. She is in the editorial board of Revista de Neurologia, associate editor for Cephalalgia, Headache, Neurologia, Frontiers of Neurology and The Journal of Headache and Pain. She is a member of the Clinical Trials Guidelines Committee of the International Headache Society. She has edited the Guidelines for the Diagnosis and Treatment of Headache of the Spanish Neurological Society. She is the founder of ExternalRef removed. Pozo-Rosich P does not own stocks from any pharmaceutical company. Cubera-Borrós G, Gallardo VJ and Vilà-Balló A report no disclosures.